Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Wohl

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2011
Responsive layer-by-layer materials for drug deliveryBenjamin M Wohl, Johan F J Engbersen
Chemical Communications (Cambridge, England)|November 19, 2015
Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugsMille B L Kryger, Søren L Pedersen, Benjamin M Wohl, et al.
Chemical Communications (Cambridge, England)|February 23, 2013
Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drugMille B L Kryger, Benjamin M Wohl, Anton A A Smith, et al.
Biomacromolecules|October 26, 2013
Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugsBenjamin M Wohl, Anton A A Smith, Mille B L Kryger, et al.
Macromolecular Bioscience|October 10, 2013
Macromolecular prodrugs for controlled delivery of ribavirinMille B L Kryger, Anton A A Smith, Benjamin M Wohl, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammationBenjamin M Wohl, Anton A A Smith, Bettina E B Jensen, et al.
Biomacromolecules|April 9, 2013
Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophagesSidsel Ø Andreasen, Siow-Feng Chong, Benjamin M Wohl, et al.
Chemical Communications (Cambridge, England)|October 7, 2014
Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugsAnders Kock, Kaja Zuwala, Anton A A Smith, et al.
Advanced Healthcare Materials|August 19, 2014
Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cellsPau Ruiz-Sanchis, Benjamin M Wohl, Anton A A Smith, et al.
Advanced Healthcare Materials|January 11, 2014
Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drugAnton A A Smith, Benjamin M Wohl, Mille B L Kryger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 20, 2011
Responsive layer-by-layer materials for drug deliveryBenjamin M Wohl, Johan F J Engbersen
Chemical Communications (Cambridge, England)|November 19, 2015
Tools of gene transfer applied to the intracellular delivery of non-nucleic acid polyanionic drugsMille B L Kryger, Søren L Pedersen, Benjamin M Wohl, et al.
Chemical Communications (Cambridge, England)|February 23, 2013
Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drugMille B L Kryger, Benjamin M Wohl, Anton A A Smith, et al.
Biomacromolecules|October 26, 2013
Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugsBenjamin M Wohl, Anton A A Smith, Mille B L Kryger, et al.
Macromolecular Bioscience|October 10, 2013
Macromolecular prodrugs for controlled delivery of ribavirinMille B L Kryger, Anton A A Smith, Benjamin M Wohl, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammationBenjamin M Wohl, Anton A A Smith, Bettina E B Jensen, et al.
Biomacromolecules|April 9, 2013
Poly(vinyl alcohol) physical hydrogel nanoparticles, not polymer solutions, exert inhibition of nitric oxide synthesis in cultured macrophagesSidsel Ø Andreasen, Siow-Feng Chong, Benjamin M Wohl, et al.
Chemical Communications (Cambridge, England)|October 7, 2014
Disulfide reshuffling triggers the release of a thiol-free anti-HIV agent to make up fast-acting, potent macromolecular prodrugsAnders Kock, Kaja Zuwala, Anton A A Smith, et al.
Advanced Healthcare Materials|August 19, 2014
Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cellsPau Ruiz-Sanchis, Benjamin M Wohl, Anton A A Smith, et al.
Advanced Healthcare Materials|January 11, 2014
Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drugAnton A A Smith, Benjamin M Wohl, Mille B L Kryger, et al.
Pageof 2